Hepatitis A virus RNA+Parvovirus B19 DNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection

HAV RNA+B19V DNA Plas Donr NAA+probe-Imp

Definition

Simultaneously detects hepatitis A virus (HAV) RNA (genotypes 1-3) and parvovirus B19 (B19) DNA (genotypes 1-3) in human donor plasma, either from whole blood (recovered plasma) or collected by apheresis, prior to further manufacture. The aim is to reduce the B19 burden and remove HAV from plasma pools. This term represents the composite result of the individual HAV qualitative test and B19 quantitative test. If either result is reactive, the composite result is reactive; otherwise, it is nonreactive. Plasma may be tested as individual specimens or in pools. Not intended for use on samples of cord blood or as an aid in diagnosis. This term was created for, but is not limited in use to, the cobas TaqScreen DPX test kit.

3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B19; B19 virus; B19V; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Donr; Fifth Disease; HAV; HAV RNA+B19V; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis A; Hepatitis type A; Hepatology; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Parvo; Parvo virus; Parvov; Parvovirus type b19; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification

26 further terms